Mereo BioPharma Group PLC Sustainability Reports
Mereo BioPharma Group PLC is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics for rare diseases.
Sector: Manufacturing
Country: United Kingdom
Exchange: London Stock Exchange
LEI: 213800U8JQHIJOS5AS09
FIGI: BBG009Q0HV95
9 reports from 2016 to 2025
